News
6h
Zacks Investment Research on MSNTesla Losing Steam in Europe: What's Impeding Its Growth?Tesla’s TSLA car sales dropped significantly in several European countries in May, which marks the fifth straight month of ...
Bloomberg recently reported that Tesla will launch its first robotaxis in Austin on June 12. The launch marks what could be ...
Elon Musk's decision to cancel the planned low-cost $25,000 EV, known as Model 2, has left Tesla executives divided. This ...
BioNTech and Bristol Myers Squibb have agreed to jointly develop and commercialize BioNTech's BNT327 cancer-drug candidate in a deal potentially worth more than $11 billion to the German drugmaker.
19h
The Cool Down on MSNTesla driver shares chilling footage of Full Self-Driving failure during routine trip: 'There's absolutely nothing you could've done'A Tesla driver shared disturbing dashcam footage that may give consumers pause about trusting the electric vehicle automaker ...
BioNTech and Bristol Myers Squibb have agreed to jointly develop and commercialize BioNTech's BNT327 cancer-drug candidate in a deal potentially worth more than $11 billion to the German drugmaker.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results